Skip to content

Effect of intravenous dexmedetomidine and remifentanil on cardiovascular response to extubation

Comparative study of the effect of intravenous dexmedetomidine and remifentanil on cardiovascular response to extubation in awake patients undergoing surgery.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200825048515N74
Enrollment
90
Registered
2024-02-18
Start date
2024-03-05
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery. Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

Interventions

Intervention 1: The first intervention group: Induction of anesthesia in patients with propofol (2 mg/kg), fentanyl 2 µg/kg and atracurium (0.5 mg/kg). Then, in this group, normal saline 70 cc will be

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Candidate for elective surgery under general anesthesia Age range from 20 to 60 years American Society of Anesthesiologists (ASA) class equal to 1 or 2 Weight 55 to 85 kg (body mass index 18.5-24.9 kg/m2) Consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy Having underlying diseases (including diabetes, chronic lung disease, cardiovascular disease, uncontrolled blood pressure, kidney failure) Having a heart rate of less than 60 beats/minute or a systolic blood pressure of less than 90 mmHg upon entering the study. Having an allergy to the drugs used Drug use

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: Before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Monitoring device.;Diastolic blood pressure. Timepoint: Before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Monitoring device.;Heart rate. Timepoint: Before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Monitoring device.;Oxygen saturation (SPO2). Timepoint: Before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Monitoring device.

Secondary

MeasureTime frame
Tachycardia. Timepoint: before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Heart rate more than 100 beats per minute.;Bradycardia. Timepoint: before induction of anesthesia, before extubation, 1, 3, 5, and 10 minutes after extubation. Method of measurement: Heart rate less than 60 beats per minute.;Cough. Timepoint: After extubation. Method of measurement: Observation.;Laryngospasm. Timepoint: After extubation. Method of measurement: Observation.;Hypoxia. Timepoint: After extubation. Method of measurement: Oxygen less than 60 bpm.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Shetabi

Esfahan University of Medical Sciences

hamid.shetabi@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026